EverSource Wealth Advisors’s RAPT Therapeutics RAPT Stock Holding History

EverSource Wealth Advisors’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$678	–	4481
2025 Q4	$678	Sell	20 -38	-66%	-$1.18K	﹤0.01%	3802
2025 Q3	$1.5K	Buy	58 +2	+4%	+$26	﹤0.01%	3623
2025 Q2	$448	Sell	56 -35	-38%	-$267	﹤0.01%	3921
2025 Q1	$888	Buy	91 +22	+32%	+$216	﹤0.01%	3273
2024 Q4	$866	Buy	69 +53	+331%	+$673	﹤0.01%	3017
2024 Q3	$255	Hold	16	–	–	﹤0.01%	2941
2024 Q2	$399	Buy	+16	New	+$739	﹤0.01%	2932

EverSource Wealth Advisors's RAPT Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 20 shares — an estimated $678 sold.

EverSource Wealth Advisors first reported a position in RAPT in Q2 2024 and held it in 7 quarters. The position peaked at $1.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

EverSource Wealth Advisors reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 20 RAPT Therapeutics shares in Q1 2026, an estimated $678.
EverSource Wealth Advisors first reported a position in RAPT Therapeutics in Q2 2024 and held it in 7 quarters.
EverSource Wealth Advisors's RAPT Therapeutics position peaked at $1.5K in Q3 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.